MannKind Study to assess safety, efficacy and treatment experience of starting inhaled insulin in youth aged 10 to
Copyright MatchingDonors.com©️ 2025 All rights reserved.
MannKind Study to assess safety, efficacy and treatment experience of starting inhaled insulin in youth aged 10 to
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions for …
NEW YORK, Feb. 9, 2026 /PRNewswire/ — Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, is proud to announce Land O’Frost, a third-generation, …
Northwest Health – Porter offers a variety of diabetes education for the community. Class sizes are limited to ensure proper social distancing and masks are required. Pre-registration is required. Classes …
In addition to their Glycoadvanced feline diet, the pet nutrition company said they will be launching Royal Canin Veterinary Fresh Nutrition later in 2026. The line will feature gently cooked …
GRAND FORKS – The Altru Family YMCA has once again launched Health Trip, a 60-day program designed to encourage healthy lifestyle choices and daily exercise during the winter months. Health …
MiniMed Go™ is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple …
PASADENA, Calif.–(BUSINESS WIRE)–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from two Phase 1/2a clinical trials of ARO-INHBE and ARO-ALK7, the company’s investigational RNA interference (RNAi) therapeutics being developed …
Allo-Evasion™ 5.0-engineered iPSC beta islets are designed to overcome immune rejection and provide durable glucose control without chronic immunosuppressionCompelling preclinical data demonstrate rapid reversal of diabetes and sustained normoglycemia, human …
Groundbreaking results from two NECTAR trials were presented at TCT 2025 SAN FRANCISCO, Oct. 27, 2025 /PRNewswire/ — Neurotronic, Inc., a developer of multi-organ denervation to treat complex cardiovascular and metabolic disease, …
Today’s Diabetes News, your ultimate destination for up-to-date and insightful information on diabetes, health tips, and living a fulfilling life with diabetes. Our mission is to empower and support individuals with diabetes, their loved ones, and the wider community by providing reliable, relevant, and engaging content that fosters a healthier and happier life.
Copyright MatchingDonors.com©️ 2025 All rights reserved.
tag -->